Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson’s disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a motor disorder that involves death of dopaminergic neurons in the substantia nigra pars compacta. Parkin is an autosomal recessive gene that is mutated in early onset PD. We investigated the role of parkin and autophagic clearance in postmortem nigrostriatal tissues from 22 non-familial sporadic PD patients and 15 control samples. Parkin was insoluble with altered cytosolic expression in the nigrostriatum of sporadic PD. Parkin insolubility was associated with lack of degradation of ubiquitinated proteins and accumulation of α-Synuclein and parkin in autophagosomes, suggesting autophagic defects in PD. To test parkin’s role in mediating autophagic clearance, we used lentiviral gene transfer to express human wild type or mutant parkin (T240R) with α-Synuclein in the rat striatum. Lentiviral expression of α-Synuclein led to accumulation of autophagic vacuoles, while co-expression of parkin with α-Synuclein facilitated autophagic clearance. Subcellular fractionation showed accumulation of α-Synuclein and p-Tau in autophagosomes in gene transfer models, similar to the effects observed in PD brains, but parkin expression led to protein deposition into lysosomes. However, parkin loss of function mutation did not affect autophagic clearance. Taken together, these data suggest that functional parkin regulates autophagosome clearance, while decreased parkin solubility may alter normal autophagy in sporadic PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 4×
“Autophagosome accumulation could be due to lack of maturation, leading to inefficient fusion with lysosomes (Kovács et al., 1982; Iwata et al., 2005; He and Klionsky, 2009).”
InfluentialPINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944 · cited 1×
“…as part of a number of multiprotein complexes, including PINK1 (Greene et al., 2003; Clark et al., 2006; Park et al., 2006), to mediate mitophagy (Narendra et al., 2008, 2010), the Skp1-Cullin-Fbox (SCF)-like complex to facilitate proteasomal degradation of Cyclin E (Staropoli et al., 2003), and…”
How to Interpret LC3 Immunoblotting
Mizushima, N., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4600 · Cited by 2,669
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347 · cited 2×
“Dysfunction in autophagy, including chaperonmediated autophagy (CMA), was observed in PD (Ravikumar et al., 2004; Nixon et al., 2005; Sarkar et al., 2007; Pan et al., 2008) and dementia with LBs (DLB), where a-Synuclein accumulation may alter autophagy and cause lysosomal dysfunction (Cuervo et al.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“…(CMA), was observed in PD (Ravikumar et al., 2004; Nixon et al., 2005; Sarkar et al., 2007; Pan et al., 2008) and dementia with LBs (DLB), where a-Synuclein accumulation may alter autophagy and cause lysosomal dysfunction (Cuervo et al., 2004; Martinez-Vicente et al., 2008; Xilouri et al., 2009).”
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 4×
“…ascertain whether parkin function mediates clearance of autophagic vacuoles, we used non-functional T240R parkin, which is a mutant form that loses its E3 ubiquitin ligase activity, leading to autosomal recessive juvenile PD (ARJPD) (Kitada et al., 1998; Lucking et al., 2000; Shimura et al., 2000).”
InfluentialDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 5×
“Additionally, decreased parkin solubility is associated with alteration of its activity via increased phosphorylation by several kinase activities, including casein kinase 1, protein kinase A, protein kinase C (Yamamoto et al., 2005), cyclin-dependent kinase 5 (Avraham et al., 2007; Rubio de la Torre et al., 2009), c-…”
InfluentialMitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 5×
“Additionally, decreased parkin solubility is associated with alteration of its activity via increased phosphorylation by several kinase activities, including casein kinase 1, protein kinase A, protein kinase C (Yamamoto et al., 2005), cyclin-dependent kinase 5 (Avraham et al., 2007; Rubio de la Torre et al., 2009), c-…”
InfluentialPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616 · cited 2×
“Parkin is known to mediate selective autophagy of dysfunctional mitochondria (Narendra et al., 2008; Park et al., 2009; Geisler et al., 2010; Vives-Bauza et al., 2010), while a-Synuclein was suggested to impair autophagy (Winslow et al.”
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203 · cited 5×
“Additionally, decreased parkin solubility is associated with alteration of its activity via increased phosphorylation by several kinase activities, including casein kinase 1, protein kinase A, protein kinase C (Yamamoto et al., 2005), cyclin-dependent kinase 5 (Avraham et al., 2007; Rubio de la Torre et al., 2009), c-…”
Influentialα-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · cited 2×
“Additionally, a-Synuclein aggregates were previously shown to alter parkin solubility in sporadic PD (Kawahara et al., 2008) and inhibit macro-autophagy in cell models and transgenic animals (Winslow et al., 2010).”
HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.
Iwata, A., Riley, B. E., Johnston, J. A., & Kopito, R. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508786200 · Cited by 719 · cited 6×
“Autophagosome accumulation could be due to lack of maturation, leading to inefficient fusion with lysosomes (Kovács et al., 1982; Iwata et al., 2005; He and Klionsky, 2009).”
InfluentialHuntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy
Kegel, K. B., Kim, M., Sapp, E., McIntyre, C., Castaño, J. G., Aronin, N., & DiFiglia, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07268.2000 · Cited by 533
Histone deacetylase 6 interacts with the microtubule‐associated protein tau
Ding, H., Dolan, P. J., & Johnson, G. V. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05564.x · Cited by 387
Neurodegenerative lysosomal disorders: A continuum from development to late age
Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362
Koike, M., Shibata, M., Waguri, S., Yoshimura, K., Tanida, I., Kominami, E., Gotow, T., Peters, C., von Figura, K., Mizushima, N., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61253-9 · Cited by 330
Rodríguez-Navarro, J. A., Rodríguez, L., Casarejos, M. J., Solano, R. M., Gómez, A., Perucho, J., Cuervo, A. M., García de Yébenes, J., & Mena, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.014 · Cited by 298 · cited 1×
“Activation of autophagy improves dopaminergic cell survival in parkin deficient and Tau over-expressing mice (Rodriguez-Navarro et al., 2010).”
He, H., Dang, Y., Dai, F., Guo, Z., Wu, J., She, X., Pei, Y., Chen, Y., Ling, W., Wu, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303800200 · Cited by 273 · cited 2×
“LC3 is expressed as three isoforms in mammalian cells, LC3-A, LC3-B and LC3-C (He et al., 2003).”
Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A., & Li, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1833-10.2011 · Cited by 214 · cited 2×
“…activities, including casein kinase 1, protein kinase A, protein kinase C (Yamamoto et al., 2005), cyclin-dependent kinase 5 (Avraham et al., 2007; Rubio de la Torre et al., 2009), c-Abelson (Abl) (Ko et al., 2010; Imam et al., 2011) and potentially PINK1 (Kim et al., 2008; Sha et al., 2010).”
Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke
Martin-Villalba, A., Hahne, M., Kleber, S., Vogel, J., Falk, W., Schenkel, J., & Krammer, P. H. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400882 · Cited by 209 · cited 1×
“…and a-Synuclein cause late onset PD. Genome-wide association studies suggest that naturally occurring sequence variants in a-Synuclein and LRRK2, as well as Tau, constitute an increased risk for late onset sporadic PD (Martin-Villalba et al., 2001; Healy et al., 2004; Cookson and Bandmann, 2010).”
Kovács, A. L., Reith, A., & Seglen, P. O. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90020-9 · Cited by 163 · cited 4×
“Autophagosome accumulation could be due to lack of maturation, leading to inefficient fusion with lysosomes (Kovács et al., 1982; Iwata et al., 2005; He and Klionsky, 2009).”
InfluentialTakeda, A., Hashimoto, M., Mallory, M., Sundsumo, M., Hansen, L., & Masliah, E. (2000) · Acta Neuropathologica · doi:10.1007/pl00007441 · Cited by 83 · cited 2×
“, 2008) and formation of inclusions known as Lewy bodies (LBs), which primarily contain aggregated aSynuclein (Spillantini et al., 1997, 1998a,b; Wakabayashi et al., 1997; Goedert, 1999, 2001; Spillantini and Goedert, 2000; Takeda et al., 2000; Trojanowski and Lee, 2003; Lundvig et al., 2005).”
Cited by
Ge, P., Dawson, V. L., & Dawson, T. M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00367-7 · Cited by 496
Yao, R.-Q., Ren, C., Xia, Z.-F., & Yao, Y.-M. (2021) · Autophagy · doi:10.1080/15548627.2020.1725377 · Cited by 441
“Induction of pexophagy Restoring redox balance [169] Neurodegenerative diseases Dysfunction of mitochondria, impairment of RETREG1mediated reticulophagy, aberrant response of peroxisomes, leakage of lysosomes, and failure of nucleophagy by mutation of LMNA Induction of mitophagy Maintaining viability of neurons by eli…”
BackgroundAutophagy and neurodegeneration
Frake, R. A., Ricketts, T., Menzies, F. M., & Rubinsztein, D. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73944 · Cited by 332
“In addition to a role in mitophagy, Parkin has also been suggested to be involved in autophagic clearance of α-synuclein, as Parkin overexpression in a rat model system promoted autophagic clearance of toxic proteins including α-synuclein (46).”
BackgroundHebron, M. L., Lonskaya, I., & Moussa, C. E. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt192 · Cited by 325
Self-citationRole of dopamine in the pathophysiology of Parkinson’s disease
Zhou, Z. D., Yi, L. X., Wang, D. Q., Lim, T. M., & Tan, E. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00378-6 · Cited by 308
Metadata
- Authors
- Lonskaya, I., Hebron, M. L., Algarzae, N. K., Desforges, N., & Moussa, C. E.-H.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 232
- Pages
- 90-105
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2069266946
- Cited by
- 68
- References
- 23
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.